| Authors: |
Krawinski P; School of Medicine and School of Biochemistry and Immunology, Trinity College Dublin, Dublin, Ireland., Matzov D; Department of Chemical and Structural Biology, Weizmann Institute of Science, Rehovot, Israel., Ryder A; School of Medicine and School of Biochemistry and Immunology, Trinity College Dublin, Dublin, Ireland., Lal K; School of Pharmacy, Queen's University Belfast, Belfast, UK., Karlov DS; School of Pharmacy, Queen's University Belfast, Belfast, UK., Chalhoub G; Department of Pharmacology and Therapeutics, University of Liverpool, Institute of Systems, Molecular and Integrative Biology, Sherrington Building, Liverpool, UK.; Centre for Endocrinology, William Harvey Research Institute, Barts and the London School of Medicine, Queen Mary, University of London, London, UK., Mulvaney EP; ATXA Therapeutics Limited, UCD Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Belfield, Ireland., Kinsella BT; ATXA Therapeutics Limited, UCD Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Belfield, Ireland., McCormick PJ; Department of Pharmacology and Therapeutics, University of Liverpool, Institute of Systems, Molecular and Integrative Biology, Sherrington Building, Liverpool, UK.; Centre for Endocrinology, William Harvey Research Institute, Barts and the London School of Medicine, Queen Mary, University of London, London, UK., Caffrey M; School of Medicine and School of Biochemistry and Immunology, Trinity College Dublin, Dublin, Ireland. martin.caffrey@tcd.ie., Tikhonova IG; School of Pharmacy, Queen's University Belfast, Belfast, UK. i.tikhonova@qub.ac.uk., Shalev-Benami M; Department of Chemical and Structural Biology, Weizmann Institute of Science, Rehovot, Israel. moransb@weizmann.ac.il. |
